rs1555980875
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_000061.3(BTK):c.119A>G(p.Tyr40Cys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000061.3 missense
Scores
Clinical Significance
Conservation
Publications
- Bruton-type agammaglobulinemiaInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, ClinGen
- isolated growth hormone deficiency type IIIInheritance: XL Classification: STRONG, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BTK | NM_000061.3 | c.119A>G | p.Tyr40Cys | missense_variant | Exon 2 of 19 | ENST00000308731.8 | NP_000052.1 | |
| BTK | NM_001287344.2 | c.221A>G | p.Tyr74Cys | missense_variant | Exon 2 of 19 | NP_001274273.1 | ||
| BTK | NM_001287345.2 | c.119A>G | p.Tyr40Cys | missense_variant | Exon 3 of 17 | NP_001274274.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BTK | ENST00000308731.8 | c.119A>G | p.Tyr40Cys | missense_variant | Exon 2 of 19 | 1 | NM_000061.3 | ENSP00000308176.8 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
X-linked agammaglobulinemia with growth hormone deficiency Pathogenic:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 40 of the BTK protein (p.Tyr40Cys). RNA analysis indicates that this missense change induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with X-linked agammaglobulinemia (PMID: 8695804, 9260159, 12204007, 28359783). This variant is also known as c.251A>G. ClinVar contains an entry for this variant (Variation ID: 449226). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTK protein function. Studies have shown that this missense change results in the emergence of a cryptic splice site resulting in a 23-base deletion in exon 2 and introduces a premature termination codon (PMID: 8695804, 12204007, 28359783). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Published functional studies demonstrate p.(Y40C) results in a deletion of 23 nucleotides from exon 2 resulting in a frameshift/premature stop codon and absence of BTK kinase activity (PMID: 8695804); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9545398, 28359783, 9260159, 11742281, 19904586, 26417435, 27512878, 34134972, 39116841, 12204007, 39119334, 8695804)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at